All news

New tool for proteomics

New tool for proteomics

Developer of life science tools Bruker Daltonics has introduced a
new research instrument for proteomics research at the laboratory
science exhibition Pittcon, taking place in the US this week.

Plants ooze vitamin C

Plants ooze vitamin C

Scientists in the US report this week that they have developed a
new technology that increases the amount of vitamin C in plants,
including grains, by increasing the amount of the enzyme that is
responsible for recycling vitamin C.

UK diagnosis for Nestlé

UK diagnosis for Nestlé

UK microbial testing company Celsis International announced this
week that food giant Nestle has selected Celsis' recently launched
milk and cream diagnostic system for its global Research &
Development site in Konolfingen.

Sigma Tau with Thuris

Sigma Tau with Thuris

Drug development and biomedical company Thuris and Italian
pharmaceutical company Sigma-Tau Industrie Farmaceutiche Riunite on
Monday announced an expansion of their ongoing research
collaboration to develop compounds to combat brain...

Green light for Pfizer

Green light for Pfizer

The European Commission has given Pfizer the all clear to acquire
Pharmacia corporation - paving the way for the creation of the
largest pharmaceutical company in the world.

Steps forward for US cGMP

Steps forward for US cGMP

The US Food and Drug Administration announced this week that it has
accomplished the initial objectives outlined in its ongoing
initiative to modernise the agency's regulation of pharmaceutical
manufacturing and product quality.

Shire goes to court

Shire goes to court

UK Shire Pharmaceuticals group said this week that its US
subsidiary Shire Laboratories has filed a lawsuit in the US
District Court against Barr Laboratories for the infringement of
the US patent No. 6,322,819 ( '819 Patent')

Biolog patent

Biolog patent

US company Biolog this week received a patent for its Phenotype
MicroArray technology. The patent, number US 6,472,201, is granted
for comparative phenotypic analysis of two or more microorganisms
using a number of substrates within...

Research pursuits

Research pursuits

Drug discovery company Pharmacopeia and healthcare business
AstraZeneca have extended their research collaboration. The
companies announced this week that they will shift their efforts
from the generation of screening libraries to...

Agreement for 3DP, J&J

Agreement for 3DP, J&J

3-Dimensional Pharmaceuticals (3DP) said this week that the
research term under its thrombin collaboration with two of the
Johnson & Johnson family of companies, Centocor and Johnson
& Johnson Pharmaceutical Research and Development,...

Funding for TransTech

Funding for TransTech

US TransTech Pharma has completed two rounds of investments in the
company, extending over the last nine months, totalling $24.5
million (€22.8m). The investments came from its largest
shareholder, New York-based MacAndrews &...

Agreement in 3DP

Agreement in 3DP

3-Dimensional Pharmaceuticals (3DP) said this week that the
research term under its thrombin collaboration with two of the
Johnson & Johnson family of companies, Centocor and Johnson
& Johnson Pharmaceutical Research and Development,...

Inflammation investigated

Inflammation investigated

US Pharmacopeia has entered into a research collaboration focused
on inflammation with Celgene Corporation. The companies will work
together to identify promising small molecule lead compounds
suitable for further development.

IVAX remains 'active'

IVAX remains 'active'

Pharmaceutical and veterinary product manufacturer IVAX corporation
has acquired ChemSource, a manufacturer of active pharmaceutical
ingredients based in Puerto Rico.

Rhodia losses

Rhodia losses

French specialty chemicals company Rhodia today reported net sales
of €6,617 million in 2002, representing a nine per cent drop
compared with 2001.

Agreeing on liver cells

Agreeing on liver cells

Exten Industries reported today that its wholly owned subsidiary,
MultiCell Technologies, a liver cell engineering and research
organisation in Warwick, US has just signed a nonexclusive license
agreement with a major pharmaceutical...

Patent for HCS

Patent for HCS

High Content Screening company Cellomics announced today that the
Canadian Intellectual Property Office has issued Cellomics'
Canadian Patent No. 2,328,194 entitled 'A System for Cell-Based
Screening.'

Follow us

Products

View more

Webinars